Report Detail
Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Insights, Forecast to 2025
- RnM3541599 |
- 19 June, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Other
HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.
The global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Molecular Human Papillomavirus (HPV) Diagnostic Equipment market based on company, product type, end user and key regions.
This report studies the global market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Molecular Human Papillomavirus (HPV) Diagnostic Equipment in these regions.
This research report categorizes the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market by top players/brands, region, type and end user. This report also studies the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation
Greiner Bio-One International GmbH (Greiner Holding AG)
Enzo Biochem Inc.
Norgen Biotek Corp.
DiagCor Bioscience Inc Ltd
Hybribio Limited
Zytovision GmbH
Arbor Vita Corporation
Medical & Biological Laboratories Co., Ltd
Fujirebio Diagnostics, Inc.
Market size by Product
Services
Assay kits
System
Market size by End User
Hosptial
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Molecular Human Papillomavirus (HPV) Diagnostic Equipment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Molecular Human Papillomavirus (HPV) Diagnostic Equipment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Molecular Human Papillomavirus (HPV) Diagnostic Equipment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by Product
- 1.4.2 Services
- 1.4.3 Assay kits
- 1.4.4 System
- 1.5 Market by End User
- 1.5.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by End User
- 1.5.2 Hosptial
- 1.5.3 Clinic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size
- 2.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue 2014-2025
- 2.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales 2014-2025
- 2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Growth Rate by Regions
- 2.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Regions
- 2.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Manufacturers
- 3.1.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Manufacturers
- 3.1.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Market Share by Manufacturers
- 3.1.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
- 3.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers
- 3.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers (2014-2019)
- 3.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Share by Manufacturers (2014-2019)
- 3.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Manufacturers
- 3.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Manufacturing Base Distribution, Product Types
- 3.4.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Type
- 3.4.3 Date of International Manufacturers Enter into Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Product
- 4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Product
- 4.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Breakdown Data by End User
6 North America
- 6.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Countries
- 6.1.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Countries
- 6.1.2 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Product
- 6.3 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by End User
7 Europe
- 7.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Countries
- 7.1.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Countries
- 7.1.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Product
- 7.3 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment by End User
8 Asia Pacific
- 8.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Countries
- 8.1.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Countries
- 8.1.2 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Product
- 8.3 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment by End User
9 Central & South America
- 9.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Countries
- 9.1.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Countries
- 9.1.2 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Product
- 9.3 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Countries
- 10.1.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales by Countries
- 10.1.2 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment by Product
- 10.3 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment by End User
11 Company Profiles
- 11.1 F. Hoffmann-La Roche Ltd.
- 11.1.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 F. Hoffmann-La Roche Ltd. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 F. Hoffmann-La Roche Ltd. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.2 Agilent Technologies, Inc.
- 11.2.1 Agilent Technologies, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Agilent Technologies, Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Agilent Technologies, Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.2.5 Agilent Technologies, Inc. Recent Development
- 11.3 Becton, Dickinson and Company
- 11.3.1 Becton, Dickinson and Company Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Becton, Dickinson and Company Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Becton, Dickinson and Company Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.3.5 Becton, Dickinson and Company Recent Development
- 11.4 Qiagen N.V.
- 11.4.1 Qiagen N.V. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Qiagen N.V. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Qiagen N.V. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.4.5 Qiagen N.V. Recent Development
- 11.5 Thermo Fisher Scientific Inc.
- 11.5.1 Thermo Fisher Scientific Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Thermo Fisher Scientific Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Thermo Fisher Scientific Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.5.5 Thermo Fisher Scientific Inc. Recent Development
- 11.6 Abbott Laboratories
- 11.6.1 Abbott Laboratories Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Abbott Laboratories Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Abbott Laboratories Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.6.5 Abbott Laboratories Recent Development
- 11.7 Hologic Inc.
- 11.7.1 Hologic Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Hologic Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Hologic Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.7.5 Hologic Inc. Recent Development
- 11.8 Cepheid Inc.
- 11.8.1 Cepheid Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Cepheid Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Cepheid Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.8.5 Cepheid Inc. Recent Development
- 11.9 Seegene Inc.
- 11.9.1 Seegene Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Seegene Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Seegene Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.9.5 Seegene Inc. Recent Development
- 11.10 Takara Bio Inc.
- 11.10.1 Takara Bio Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Takara Bio Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Takara Bio Inc. Molecular Human Papillomavirus (HPV) Diagnostic Equipment Products Offered
- 11.10.5 Takara Bio Inc. Recent Development
- 11.11 DaAn Gene Co., Ltd. of Sun Yat-Sen University
- 11.12 Promega Corporation
- 11.13 Greiner Bio-One International GmbH (Greiner Holding AG)
- 11.14 Enzo Biochem Inc.
- 11.15 Norgen Biotek Corp.
- 11.16 DiagCor Bioscience Inc Ltd
- 11.17 Hybribio Limited
- 11.18 Zytovision GmbH
- 11.19 Arbor Vita Corporation
- 11.20 Medical & Biological Laboratories Co., Ltd
- 11.21 Fujirebio Diagnostics, Inc.
12 Future Forecast
- 12.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Forecast by Regions
- 12.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Forecast by Regions 2019-2025
- 12.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Forecast by Product
- 12.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Forecast by Product 2019-2025
- 12.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Forecast by Product 2019-2025
- 12.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Forecast by End User
- 12.4 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Forecast
- 12.5 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Forecast
- 12.6 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Forecast
- 12.7 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Forecast
- 12.8 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Molecular Human Papillomavirus (HPV) Diagnostic Equipment . Industry analysis & Market Report on Molecular Human Papillomavirus (HPV) Diagnostic Equipment is a syndicated market report, published as Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Molecular Human Papillomavirus (HPV) Diagnostic Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
